Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death
10.1002/j.1460-2075.1992.tb05481.x · 1992
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
10.1073/pnas.192461099 · 2002
A new member of the immunoglobulin superfamily—CTLA-4
10.1038/328267a0 · 1987
Enhancement of antitumor immunity by CTLA-4 blockade
10.1126/science.271.5256.1734 · 1996
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
10.1016/j.intimp.2018.06.001 · 2018
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
10.1158/2159-8290.cd-18-0367 · 2018
Improved survival with ipilimumab in patients with metastatic melanoma
10.1056/nejmoa1003466 · 2010
Nivolumab in previously untreated melanoma without BRAF mutation
10.1056/nejmoa1412082 · 2015
Pembrolizumab for Early Triple-Negative Breast Cancer
10.1056/nejmoa1910549 · 2020
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
10.1056/nejmoa2202809 · 2022
The Lymphatic System in Disease Processes and Cancer Progression
10.1146/annurev-bioeng-112315-031200 · 2016
Lymph node – an organ for T-cell activation and pathogen defense
10.1111/imr.12399 · 2016
Progression of Metastasis through Lymphatic System
10.3390/cells10030627 · 2021
Solid stress impairs lymphocyte infiltration into lymph-node metastases
10.1038/s41551-021-00766-1 · 2021
Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes
10.1084/jem.20221847 · 2023
Lymph node colonization induces tumor-immune tolerance to promote distant metastasis
10.1016/j.cell.2022.04.019 · 2022
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients
10.1038/s41467-020-17046-2 · 2020
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
10.1126/science.aal3662 · 2018
Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice
10.1126/science.aal3622 · 2018
Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes
10.1097/coc.0b013e318246b4e9 · 2013
The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy
10.21873/anticanres.12801 · 2018
Lymph node ratio as a prognostic factor in head and neck cancer patients
10.1186/s13014-015-0490-9 · 2015
Prognostic information from sentinel lymph node biopsy in patients with thick melanoma
10.1001/archsurg.2010.115 · 2010
The lymph node ratio as prognostic factor in node-positive breast cancer
10.1016/j.radonc.2003.10.015 · 2004
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
10.1016/j.ccell.2020.09.001 · 2020
The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes
10.1016/j.cell.2022.09.020 · 2022
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
10.1016/s1470-2045(15)70122-1 · 2015
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation
10.1126/sciimmunol.abn8097 · 2022
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
10.1056/nejmoa1613210 · 2017
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy
10.1172/jci.insight.124507 · 2018
Chemotherapy but Not the Tumor Draining Lymph Nodes Determine the Immunotherapy Response in Secondary Tumors
10.1016/j.isci.2020.101056 · 2020
Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors
10.1016/j.ebiom.2022.104265 · 2022
Effect of lymph node dissection and adjuvant therapy in patients with sentinel node+ melanoma: An observational multicenter study
10.1200/jco.2023.41.16_suppl.e21569 · 2023
Lymphatic migration of unconventional T cells promotes site-specific immunity in distinct lymph nodes
10.1016/j.immuni.2022.07.019 · 2022
Same yet different—how lymph node heterogeneity affects immune responses
10.1038/s41577-023-00965-8 · 2024
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
10.1126/science.8171322 · 1994
Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness
10.4049/jimmunol.155.4.1685 · 1995
Absence of lymph nodes in lymphotoxin-alpha(LT alpha)-deficient mice is due to abnormal organ development, not defective lymphocyte migration
1995
The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes
10.1038/ni.3101 · 2015
Assessing breast lymphoedema following breast cancer treatment using indocyanine green lymphography
10.1007/s10549-020-05661-y · 2020
